By Mill Chart
Last update: Jan 27, 2022
A possible breakout setup was detected on CVS HEALTH CORP (NYSE:CVS) by our stockscreener. A breakout pattern is formed when a stock consolidates after a strong rise up. We note that this pattern is detected purely based on technical analysis and whether the breakout actually materializes remains to be seen. It could be interesting to keep an eye on NYSE:CVS.
ChartMill assigns a Technical Rating to every stock. This score ranges from 0 to 10 and is updated daily. The score is determined by evaluating multiple technical indicators and properties.
Taking everything into account, CVS scores 10 out of 10 in our technical rating. Both in the recent history as in the last year, CVS has proven to be a steady performer, scoring decent points in every aspect analyzed.
Besides the Technical Rating, ChartMill also assign a Setup Rating to every stock. This setup score also ranges from 0 to 10 and determines to which extend the stock is consolidating. This is achieved by evaluating multiple short term technical indicators. NYSE:CVS currently has a 9 as setup rating:
CVS has an excellent technical rating and also presents a decent setup pattern. Prices have been consolidating lately. There is a resistance zone just above the current price starting at 106.22. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 104.17, a Stop Loss order could be placed below this zone. Very recently a Pocket Pivot signal was observed. This is another positive sign.
For a potential trade one would typically wait until the stock breaks out of the consolidation zone to enter the stock and it could be sold again for a loss when it would fall back below the zone.
Of course, there are many ways to trade or not trade NYSE:CVS and this article should in no way be interpreted as trading advice. The article is purely based on an automated technical analysis and just points out the technical observations. Always make your own analysis and trade at your own responsibility.
Our Breakout analyzer lists more breakout setups and is updated daily.
CVS HEALTH CORP
NYSE:CVS (4/19/2024, 6:00:30 PM)
After market: 69.6 -0.15 (-0.22%)69.75
+0.36 (+0.52%)
AbbVie is working against numerous biosimilar versions of Humira. But one has "stepped up dramatically."
Fortify your portfolio against increased market volatility with three defensive stocks that perform no matter what the economic climate.
Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment.
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
Stocks with women CEOs often outperform their counterparts. These three companies are great examples of that.
Although the market may be grumbling over certain issues, concerned investors can trust these healthcare stocks to deliver the goods.
/PRNewswire/ -- Aetna Better Health of Michigan, a CVS Health® company (NYSE: CVS), has been recommended by the Michigan Department of Health and Human...
The indexes and leading stocks are generally holding key levels.
CVS Health Corp. drug plans will cover over-the-counter oral birth control in the US, a step that further removes barriers to obtaining oral contraception as reproductive rights increasingly come under fire.
/PRNewswire/ -- To support the next generation of pharmacists, CVS Health® (NYSE: CVS) today announced two new offerings for pharmacy students: an enhanced...
The federal agency that administers the Medicare program just approved a 3.7% payment rate increase. Here's why that's bad for insurance stocks.